DGAT1 and type 2 diabetes mellitus: Since there are limited data on the phenotype of heterozygote (Dgat1+/-) mice [1], these were included in the study to give some perspective on how much inhibition of DGAT1 might be required to treat obesity and type 2 diabetes.